The Yeast Flora of the Anogenital Region in Diabetic Girls

Sonck, C. E.

doi:10.1001/archderm.1963.01590240170029

Cited by 41 publications

(10 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They also lend further weight to the supposition that poorly controlled diabetics are more at risk of yeast infection than others (Sonck and Somersalo, 1963;Knight and Fletcher, 1971). Finally, the transient nature both of the yeast overgrowth and of the antibody response should be borne in mind when diabetic patients are investigated for suspected systemic yeast infection.…”

Section: Discussionmentioning

confidence: 91%

“…The predisposing effect of diabetes has been confirmed by animal experiments (Andriole and Hasenclever, 1962;Hurley, 1966;Louria, et al, 1966;Van Cutsem and Thienpont, 1971) in which an induced diabetic state was associated with increased susceptibility to infection by pathogenic Candida species. Previous studies had shown the prevalence of yeasts to be greater among diabetics than among normal subjects (Sonck and Somersalo, 1963; Barlow and Chattaway, 1969), although this has not been the finding of all workers (Peters et al, 1966). The disparity in results may of course, be due to differences in sampling techniques, sites sampled, and selection of subjects.…”

mentioning

confidence: 90%

See 1 more Smart Citation

Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients.

Odds¹,

Evans²,

Taylor³

et al. 1978

J Clin Pathol

View full text Add to dashboard Cite

SUMMARY The prevalence of oral yeasts and humoral precipitating antibodies to candida was estimated in 204 unselected diabetic patients (172 outpatients and 32 inpatients). Yeasts, mainly Candida albicans, were isolated from the mouths of 41 % of the outpatients and precipitins were found in 17-5 % although none of the patients had clinically overt candidiasis. The extent of oral yeast colonisation and incidence of antibodies was not related to their antidiabetic treatment or to the duration of their diabetes. It was, however, related to the blood glucose and urine sugar levels at the time they were sampled, the highest incidence being among the diabetic inpatients with high blood glucose levels at the time of sampling and the lowest among outpatients with normal blood glucose levels at the time of sampling. There was no such correlation when diabetic control over the previous 12-month period was considered.

show abstract

Section: Discussionmentioning

confidence: 91%

mentioning

confidence: 90%

Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients.

Odds¹,

Evans²,

Taylor³

et al. 1978

J Clin Pathol

View full text Add to dashboard Cite

show abstract

“…[1][2][3][4][5] We have earlier reported significantly high prevalence of Candida(C.) colonisation in patients with diabetes mellitus and its relationship with poor glycaemic control. Candida glabrata was the most common organism grown followed by C. albicans in the high vaginal swabs of patients with diabetes mellitus in contrast to non-diabetic subjects where C. albicans was the most common organism grown.…”

Section: Introductionmentioning

confidence: 99%

Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy

Goswami

Banerjee

et al. 2006

Journal of Infection

View full text Add to dashboard Cite

“…Further, chronic recurring VVC may be a marker of diabetes [9]. Several studies report increased rates of asymptomatic vaginal carriage rates of Candida species and incidence of symptomatic infection in diabetic women, but results are inconsistent [5,10-14]. While some show no increase in carriage of vaginal Candida [5], those demonstrating increased Candida carriage in female diabetes patients do not examine the effect of glucose control or diabetes type [12,14].…”

Section: Introductionmentioning

confidence: 99%

Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes

et al. 2002

View full text Add to dashboard Cite

BackgroundDiabetes mellitus increases the rate of vaginal colonization and infection with Candida speciesMethodsWe surveyed women with diabetes receiving care at either an urban or suburban diabetes clinic to examine the relationship between vaginal Candida colonization, diabetes type and duration, and HbA1c level. 101 participants completed the self-administered questionnaire and self-collected a vaginal swab for Candida culture. Candida colonization was similar by age and race.ResultsType 1 diabetics were three times as likely as type 2 diabetics to be colonized with any Candida species (OR = 3.4; 95% CI: 1.03, 11.41; p = 0.04); even after adjusting for abnormal HbA1c, which had an independent effect (OR = 1.4; 95% CI: 1.04, 1.76; p = 0.02). Recent antibiotic use (OR = 4.5; 95% CI: 1.18, 16.79; p = 0.03), lifetime history of chlamydia (OR = 5.8; 95% CI: 1.09, 30.54; p = 0.04), and performing oral sex during the past 2 weeks (OR = 4.9; 95% CI:0.84, 28.27; p = 0.08) were also associated with Candida carriage after adjusting for diabetic type and abnormal HbA1c. C. albicans was isolated from the majority of colonized type 1 participants (56%), while C. glabrata was the most common isolate among colonized type 2 participants (54%).ConclusionsImproving glucose control and possibly modifying sexual behavior may reduce risk of Candida colonization, and potentially symptomatic infection, among women with diabetes.

show abstract

The Yeast Flora of the Anogenital Region in Diabetic Girls

Cited by 41 publications

References 5 publications

Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients.

Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients.

Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy

Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes

Contact Info

Product

Resources

About